Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jurij Bogovic"'
Autor:
Ida Kappel Buhl, Troels Dreier Christensen, Anna Sofie Kappel Buhl, Ib Jarle Christensen, Eva Balslev, Ann Søegaard Knop, Bent Ejlertsen, Iben Kümler, Hella Danø, Adam Andrzej Luczak, Sven Tyge Langkjer, Søren Linnet, Erik Hugger Jakobsen, Jurij Bogovic, Vesna Glavicic, Ulla Hald Buhl, Steen Knudsen, Peter Buhl Jensen, Dorte Nielsen
Background Even with positive oestrogen receptor (ER+) status some advanced breast cancer (ABC) patients fail to benefit from endocrine therapy (ET). A method that previously predicted other drugs in various cancers was evaluated. Here multigene mark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f74f0164074f9f5c285dc7b7b2cb16b
https://doi.org/10.21203/rs.2.10981/v1
https://doi.org/10.21203/rs.2.10981/v1
Autor:
Troels Dreier Christensen, Anna Sofie Kappel Buhl, Jurij Bogovic, Knud Mejer Nelausen, Ib Jarle Christensen, Eva Harder Brix, Ann Knoop, Else Svensson, Steen Knudsen, Sven Tyge Langkjer, Søren Linnet, Adam Luczak, Anker Jon Hansen, Peter Buhl Jensen, Eva Balslev, Erik Jakobsen, Dorte Nielsen, Bent Ejlertsen, Annie Rasmussen, Vesna Glavicic
Publikováno v:
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391-400 . https://doi.org/10.1007/s10549-018-4918-4
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4
Breast Cancer Research and Treatment
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4
Breast Cancer Research and Treatment
PURPOSE: Anthracyclines remain a cornerstone in the treatment of primary and advanced breast cancer (BC). This study has evaluated the predictive value of a multigene mRNA-based drug response predictor (DRP) in the treatment of advanced BC with epiru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f4d0f127f0dafb654c610d7a725c80a
https://curis.ku.dk/portal/da/publications/predicting-efficacy-of-epirubicin-by-a-multigene-assay-in-advanced-breast-cancer-within-a-danish-breast-cancer-cooperative-group-dbcg-cohort(d94324d4-b6ee-484b-9f67-4ebcfeaf6560).html
https://curis.ku.dk/portal/da/publications/predicting-efficacy-of-epirubicin-by-a-multigene-assay-in-advanced-breast-cancer-within-a-danish-breast-cancer-cooperative-group-dbcg-cohort(d94324d4-b6ee-484b-9f67-4ebcfeaf6560).html
Autor:
Hella Danoe, Thomas Jensen, Erik Jakobsen, Vesna Glavicic, Jurij Bogovic, Dorte Nielsen, Eva Balslev, Annie Rasmussen, Peter Buhl Jensen, AS Knoop, Bent Ejlertsen, Ida Kappel Buhl, Ulrik Lassen, Joergen Hansen, Ulla Hald Buhl, Sven Tyge Langkjer, Steen Knudsen, Anker Jon Hansen, Mogens Winkel Madsen, Soeren Linnet
Publikováno v:
Hugger Jakobsen, E, Nielsen, D, Danø, H, Linnet, S, Hansen, J, Lassen, U N, Balslev, E, Glavicic, V, Bogovic, J, Knudsen, S, Ejlertsen, B, Søegaard Knoop, A, Buhl, U H, Madsen, M W, Buhl, I K, Hansen, A, Jensen, T, Rasmussen, A, Jensen, P B & Langkjer, S T 2018, ' Liposomal cisplatin response prediction in heavily pretreated breast cancer patients: A multigene biomarker in a prospective phase 2 study ', Journal of Clinical Oncology, vol. 36, no. 15 Suppl., e13077 . https://doi.org/10.1200/JCO.2018.36.15_suppl.e13077
e13077Background: In an ongoing, open-label Phase 2 study liposomal cisplatin (LiPlaCis) was evaluated in metastatic breast cancer (mBC) patients selected by a cisplatin-specific mRNA-based drug re...
Autor:
Jurij Bogovic, Eva Harder Brix, Knud Mejer Nelausen, Dorte Nielsen, Troels Dreier Christensen, Vesna Glavicic, Bent Ejlertsen, Eva Balslev, Ann Knoop, Anna Sofie Kappel Buhl, Adam Luczak, Sven Tyge Langkjer, Peter Buhl Jensen, Steen Knudsen, Anker Jon Hansen, Else Svensson, Erik Jakobsen, Soeren Linnet, Ib Jarle Christensen, Annie Rasmussen
Publikováno v:
Journal of Clinical Oncology. 35:1071-1071
1071 Background: Epirubicin remains a cornerstone in the treatment of primary and advanced breast cancer. This study evaluated the predictive effect of a multigene mRNA-based Drug Response Predictor (DRP) in the treatment of advanced breast cancer (A
Autor:
Knud Mejer Nelausen, Vesna Glavicic, Anna Sofie Kappel Buhl, Steen Knudsen, Soeren Linnet, Sven Tyge Langkjer, Troels Dreier Christensen, Peter Buhl Jensen, Adam Luczak, AS Knoop, Dorte Nielsen, Eva Harder Brix, Jurij Bogovic, Eva Balslev, Ulla Hald Buhl, Iben Kümler, Bent Ejlertsen, Erik Jakobsen, Ib Jarle Christensen, Peter Michael Vestlev
Publikováno v:
Journal of Clinical Oncology. 35:e12532-e12532
e12532 Background: Exemestaneis a steroidal aromatase inhibitor used in the treatment of postmenopausal patients with estrogen receptor(ER)-positive adjuvant and advanced breast cancer. We aimed to determine the predictive value of a multigene mRNA-b